recent peer-reviewed publications
Chooback, N., Shen, Y., Jones, M., Kasaian, K., Martin, M., Ng, T., et al. Ho, C. (2017, 6 28). Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy. Current Oncology, 24(3), 251.
Chow-White, P., Ha, D., & Laskin, J. (2017). Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists. Human Resources for Health.
Thibodeau, M. L., Reisle, C., Zhao, E., Martin, L. A., Alwelaie, Y., Mungall, K. L., et al. Jones, S. J. (2017, 9 16). Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma. Cold Springs Harbour Molecular Case Studies, 3(5), mcs.a001628. doi:10.1101/mcs.a001628
Weymann, D., Laskin, J., Roscoe, R., Schrader, K., Chia, S., Yip, S., et al. Regier, D. (2017, 5 1). The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Molecular Genetics & Genomic Medicine, 5(3), 251-260.
International Society for Biological and Environmental Repositories (ISBER) 2017
Opportunities and Challenges in Tissue Procurement for Personalized OncoGenomics
UBC MEDTalks: Genomic Revolution
Personalized care in oncology: pitfalls and successes
Genome sequencing for the improvement of cancer diagnosis and treatment
The cost and cost-trajectory of whole-genome analysis to guide treatment of patients with advanced cancers
Guiding Platinum-based Chemotherapy with a Somatic Mutation Signature of BRCA1/2 Impairment
Advances in Genome Biology and Technology (AGBT) - Precision Health meeting
A mutation signature of BRCA Deficiency is associated with improved success on platinum in breast cancer
recent posters & abstracts
Personalized Medicine Summit
Comprehensive Bioinformatics Analysis of Whole Genome and Transcriptome Sequence Data from Individual Patient Tumours
Whole genome sequencing (WGS) analysis of lung adenocarcinoma: elucidating the molecular signature
Taking whole genomes to the cancer clinic: Integrative analysis for interpretation and communication of whole genome and transcriptome analysis at a tumour board
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncology
Bioinformatics for Personalized Oncogenomics: Lessons learned from analyzing whole genomes and transcriptomes from 500 patients
4th Canadian Cancer Research Conference
Genomic biomarkers of response to checkpoint inhibitor immunotherapy in the Personalized OncoGenomics cohort